Central administration of insulin-like growth factor-1 inhibits lipopolysaccharide-induced sickness behavior in mice

被引:39
|
作者
Dantzer, R
Gheusi, G
Johnson, RW
Kelley, KW
机构
[1] INSERM, U394, INRA, Lab Integrat Neurobiol, F-33077 Bordeaux, France
[2] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA
关键词
behavior; brain; insulin-like growth factor-1; lipopolysaccharide; mice;
D O I
10.1097/00001756-199902050-00015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To assess the possible modulatory effects of insulin-like growth factor-1 (IGF-1) on the brain effects of proinflammatory cytokines, male CD-1 mice were injected into the lateral ventricle of the brain with a behaviorally depressing dose (100 ng) of the cytokine inducer lipopolysaccharide (LPS) and their response to various doses of IGF-1 (0, 100 and 1000 ng) was measured during behavioral tests carried before and at various time intervals after treatment. LPS induced a profound behavioral depression that was abrogated by the higher dose of IGF-1 tested. Since the behavioral effects of LPS are mediated by the local synthesis and results of proinflammatory cytokines, these results indicate that IGF-1 interferes with the production and/or action of proinflammatory cytokines in the brain. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:289 / 292
页数:4
相关论文
共 50 条
  • [21] THE ROLE OF INSULIN-LIKE GROWTH FACTOR-1 ON STEATOHEPATITIS
    Bulur, O.
    Dal, K.
    Ertugrul, D. T.
    Aydogan, Y.
    Beyan, E.
    Karadag, I
    Unsal, O.
    VALUE IN HEALTH, 2016, 19 (07) : A839 - A839
  • [22] Challenges of insulin-like growth factor-1 testing
    Huang, Rongrong
    Shi, Junyan
    Wei, Ruhan
    Li, Jieli
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (05) : 388 - 403
  • [23] Insulin-like growth factor-1 for severe growth failure
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1261): : 43 - 44
  • [24] Nutrient regulation of insulin-like growth factor-1
    Rabkin, R
    MINERAL AND ELECTROLYTE METABOLISM, 1997, 23 (3-6) : 157 - 160
  • [25] Central Insulin and Insulin-Like Growth Factor-1 Signaling - Implications for Diabetes Associated Dementia
    Zemva, Johanna
    Schubert, Markus
    CURRENT DIABETES REVIEWS, 2011, 7 (05) : 356 - 366
  • [26] Mitigation of Ionizing Radiation-Induced Gastrointestinal Damage by Insulin-Like Growth Factor-1 in Mice
    Pejchal, Jaroslav
    Tichy, Ales
    Kmochova, Adela
    Fikejzlova, Lenka
    Kubelkova, Klara
    Milanova, Marcela
    Lierova, Anna
    Filipova, Alzbeta
    Muckova, Lubica
    Cizkova, Jana
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [27] Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion
    Sprinzl, Martin Franz
    Puschnik, Andreas
    Schlitter, Anna Melissa
    Schad, Arno
    Ackermann, Kerstin
    Esposito, Irene
    Lang, Hauke
    Galle, Peter Robert
    Weinmann, Arndt
    Heikenwaelder, Mathias
    Protzer, Ulrike
    JOURNAL OF HEPATOLOGY, 2015, 62 (04) : 863 - 870
  • [28] Decrease in Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-1 Ratio in the First Week of Stroke Is Related to Positive Outcomes
    Mattlage, Anna E.
    Rippee, Michael A.
    Sandt, Janice
    Billinger, Sandra A.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (07): : 1800 - 1806
  • [29] Steroid myopathy: Pathogenesis and effects of growth hormone and insulin-like growth factor-1 administration
    Kanda, F
    Okuda, S
    Matsushita, T
    Takatani, K
    Kimura, K
    Chihara, K
    HORMONE RESEARCH, 2001, 56 : 24 - 28
  • [30] Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C
    Kasprzak, Aldona
    Adamek, Agnieszka
    Przybyszewska, Wieslawa
    Pyda, Przemyslaw
    Szmeja, Jacek
    Seraszek-Jaros, Agnieszka
    Lanzafame, Agata
    Surdacka, Anna
    Mozer-Lisewska, Iwona
    Koczorowska, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (13) : 3867 - 3875